Jurin Mladenka, Čikoš Ana, Stepanić Višnja, Górecki Marcin, Pescitelli Gennaro, Kontrec Darko, Jakas Andreja, Dražić Tonko, Roje Marin
Laboratory for Chiral Technologies, Division of Organic Chemistry and Biochemistry, Ruđer Bošković Institute, Bijenička Cesta 54, 10000 Zagreb, Croatia.
NMR Centre, Ruđer Bošković Institute, Bijenička Cesta 54, 10000 Zagreb, Croatia.
Pharmaceuticals (Basel). 2024 Sep 24;17(10):1259. doi: 10.3390/ph17101259.
Hydantoins, a class of five-membered heterocyclic compounds, exhibit diverse biological activities. The aim of this study was to synthesize and characterize a series of novel 3,5-disubstituted hydantoins and to investigate their antiproliferative activity against human cancer cell lines. The new hydantoin derivatives - were prepared as racemic mixtures of - and -isomers via a base-assisted intramolecular amidolysis of C-3 functionalized β-lactams. The enantiomers of - and -hydantoins were separated by preparative high-performance liquid chromatography (HPLC) using -hexane/2-propanol (90/10, /) as the mobile phase. The absolute configuration of the four allyl hydantoin enantiomers was assigned based on a comparison of the experimental electronic circular dichroism (ECD) and vibrational circular dichroism (VCD) spectra with those calculated using density functional theory (DFT). The antiproliferative activity evaluated against three different human cancer cell lines: HepG2 (liver hepatocellular carcinoma), A2780 (ovarian carcinoma), and MCF7 (breast adenocarcinoma), and on the non-tumor cell line HFF1 (normal human foreskin fibroblasts) using the MTT cell proliferation assay. In silico drug-like properties and ADMET profiles were estimated using the ADMET Predictor ver. 9.5 and the online server admetSAR. Eighteen new 3,5-disubstituted hydantoins were synthesized and characterized. The compound - showed potent cytotoxic activity against the human tumor cell line MCF7 (IC = 4.5 µmol/L) and the non-tumor cell line HFF1 (IC = 12.0 µmol/L). In silico analyzes revealed that the compounds exhibited moderate water solubility and membrane permeability and are likely substrates for CYP3A4 and P-glycoprotein and have a high probability of antiarthritic activity.
乙内酰脲是一类五元杂环化合物,具有多种生物活性。本研究的目的是合成并表征一系列新型的3,5-二取代乙内酰脲,并研究它们对人癌细胞系的抗增殖活性。通过碱辅助的C-3官能化β-内酰胺的分子内酰胺解反应,制备了新的乙内酰脲衍生物,它们是外消旋混合物,包含R-和S-异构体。使用正己烷/2-丙醇(90/10,v/v)作为流动相,通过制备型高效液相色谱(HPLC)分离R-和S-乙内酰脲的对映体。基于实验电子圆二色光谱(ECD)和振动圆二色光谱(VCD)与使用密度泛函理论(DFT)计算的光谱进行比较,确定了四种烯丙基乙内酰脲对映体的绝对构型。使用MTT细胞增殖试验评估了对三种不同人癌细胞系(HepG2(肝细胞癌)、A2780(卵巢癌)和MCF7(乳腺腺癌))以及非肿瘤细胞系HFF1(正常人包皮成纤维细胞)的抗增殖活性。使用ADMET Predictor ver. 9.5和在线服务器admetSAR估算了计算机模拟的类药性质和ADMET概况。合成并表征了18种新的3,5-二取代乙内酰脲。化合物 - 对人肿瘤细胞系MCF7(IC = 4.5 µmol/L)和非肿瘤细胞系HFF1(IC = 12.0 µmol/L)表现出较强的细胞毒性活性。计算机模拟分析表明,这些化合物具有中等的水溶性和膜通透性,可能是CYP3A4和P-糖蛋白的底物,并且具有较高的抗关节炎活性概率。